Ramon Escudero-Garcia

Madrid, MD 28040, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

Opening of a phase Ib/II study to investigate the safety and efficacy of Afatinib in patients with Fanconi anemia and unresectable locally advanced or metastatic head and neck squamous cell carcinoma.

Opening of a phase Ib/II study to investigate the safety and efficacy of Afatinib in patients with Fanconi anemia and unresectable locally advanced or metastatic head and neck squamous cell carcinoma.

Journal: BMC cancer

Published: June 16, 2025

Loss of Gαq reshapes fibroblast traits and drives tumor-stroma remodeling in oral cancer progression.

Loss of Gαq reshapes fibroblast traits and drives tumor-stroma remodeling in oral cancer progression.

Journal: EMBO reports

Published: May 21, 2025

Lentiviral-mediated panErbB CAR-T cell therapy against head and neck squamous cell carcinomas for patients with Fanconi anemia.

Lentiviral-mediated panErbB CAR-T cell therapy against head and neck squamous cell carcinomas for patients with Fanconi anemia.

Journal: Molecular therapy. Oncology

Published: April 17, 2025

The G-Protein-Coupled Receptor Kinase 2 Orchestrates Hair Follicle Homeostasis.

The G-Protein-Coupled Receptor Kinase 2 Orchestrates Hair Follicle Homeostasis.

Journal: The Journal of investigative dermatology

Published: November 28, 2024

DrugAppy - An end-to-end deep learning framework for computational drug discovery.

DrugAppy - An end-to-end deep learning framework for computational drug discovery.

Journal: Computers in biology and medicine

Published: November 26, 2024

Comprehensive immune ageing reveals TREM2/TIM3 myeloid cells drive brain immune evasion.

Comprehensive immune ageing reveals TREM2/TIM3 myeloid cells drive brain immune evasion.

Journal: EBioMedicine

Published: October 23, 2024

Unraveling LINE-1 retrotransposition in head and neck squamous cell carcinoma.

Unraveling LINE-1 retrotransposition in head and neck squamous cell carcinoma.

Journal: Molecular oncology

Published: September 27, 2024

CDK7-targeted therapy effectively disrupts cell cycle progression and oncogenic signaling in head and neck cancer.

CDK7-targeted therapy effectively disrupts cell cycle progression and oncogenic signaling in head and neck cancer.

Journal: Signal transduction and targeted therapy

Published: September 02, 2024

Nonviral CRISPR/Cas9 mutagenesis for streamlined generation of mouse lung cancer models.

Nonviral CRISPR/Cas9 mutagenesis for streamlined generation of mouse lung cancer models.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 03, 2024

Nuclear versus cytoplasmic IKKα signaling in keratinocytes leads to opposite skin phenotypes and inflammatory responses, and a different predisposition to cancer.

Nuclear versus cytoplasmic IKKα signaling in keratinocytes leads to opposite skin phenotypes and inflammatory responses, and a different predisposition to cancer.

Journal: Oncogene

Published: November 20, 2023

Novel Mouse Cell Lines and In Vivo Models for Human High-Grade Neuroendocrine Lung Carcinoma, Small Cell Lung Carcinoma (SCLC), and Large Cell Neuroendocrine Carcinoma (LCNEC).

Novel Mouse Cell Lines and In Vivo Models for Human High-Grade Neuroendocrine Lung Carcinoma, Small Cell Lung Carcinoma (SCLC), and Large Cell Neuroendocrine Carcinoma (LCNEC).

Journal: International journal of molecular sciences

Published: September 20, 2023

Restored glyoxylate metabolism after AGXT gene correction and direct reprogramming of primary hyperoxaluria type 1 fibroblasts.

Restored glyoxylate metabolism after AGXT gene correction and direct reprogramming of primary hyperoxaluria type 1 fibroblasts.

Journal: iScience

Published: April 03, 2023

Showing 1-12 of 66

Last Updated: 09/26/2026